How Much Does Provigil (Modafinil) Cost in Kansas in 2026?

Brand vs. Generic Pricing in Kansas

Generic modafinil costs a fraction of brand-name Provigil at Kansas pharmacies. The manufacturer list price for Provigil (Cephalon/Teva) sits near $850 per month for a 30-count supply of 200 mg tablets. Generic modafinil 200 mg, by contrast, averages about $80 per month across Kansas retail pharmacies in 2026. That is a price difference exceeding 90%.

Multiple generic manufacturers entered the market after Cephalon's patent exclusivity ended in 2012, and competition has kept generic pricing relatively stable. The FDA-approved labeling for Provigil lists modafinil as indicated for excessive sleepiness associated with narcolepsy, obstructive sleep apnea (as an adjunct to CPAP), and shift-work disorder. The landmark US Modafinil in Narcolepsy Multicenter Study Group trial (N=283) demonstrated that modafinil 200 mg and 400 mg significantly reduced excessive daytime sleepiness on the Epworth Sleepiness Scale and improved the ability to sustain wakefulness compared to placebo (Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy, Ann Neurol 1998).

Kansas residents filling at chain pharmacies such as CVS, Walgreens, or Walmart will typically find pricing close to the $80 average, though individual stores may vary by $10 to $25 depending on their wholesale agreements. Independent pharmacies occasionally offer lower cash-pay rates if you ask directly. Always request the cash price at the counter before assuming your insurance copay is the best deal.

Kansas Medicaid Coverage for Modafinil

Kansas Medicaid does not cover Provigil or generic modafinil for narcolepsy, shift-work disorder, or off-label cognitive enhancement as of 2026. The Kansas Medicaid preferred drug list restricts coverage to specific therapeutic categories, and wakefulness-promoting agents have not been included in the formulary for standard beneficiaries.

This gap matters. Narcolepsy affects an estimated 135,000 to 200,000 people in the United States, according to the National Institute of Neurological Disorders and Stroke. Patients on Kansas Medicaid who receive a narcolepsy diagnosis face out-of-pocket costs for modafinil unless their prescriber can obtain a prior authorization through a documented medical necessity appeal, which Kansas Medicaid may consider on a case-by-case basis but does not routinely grant for this drug class.

If you are enrolled in KanCare (Kansas's Medicaid managed care program), contact your managed care organization directly. Some MCOs maintain supplemental formularies or exceptions processes that differ from the base Medicaid list. Dr. Michael Thorpy, Director of the Sleep-Wake Disorders Center at Montefiore Medical Center, has noted: "Access barriers for wakefulness-promoting agents remain a significant problem for patients with narcolepsy, particularly in states where Medicaid formularies have not kept pace with clinical guidelines."

An alternative path: if modafinil is denied, your prescriber may consider sodium oxybate or pitolisant, which may have different formulary placement under KanCare plans. Discuss these options before accepting a denial as final.

Commercial Insurance Coverage in Kansas

Most commercial insurance plans available in Kansas do cover generic modafinil, though specifics depend on the insurer and plan tier. Blue Cross Blue Shield of Kansas, Aetna, and UnitedHealthcare plans sold through the ACA marketplace or employer groups generally place generic modafinil on Tier 2 or Tier 3 of their formularies.

Typical copays range from $15 to $45 per month for generic modafinil on a Tier 2 formulary. Brand-name Provigil, when covered at all, usually sits on Tier 4 (non-preferred brand) or requires a specialty tier copay that can exceed $200 per month. Prior authorization is commonly required, and insurers typically ask for documentation of a sleep study confirming narcolepsy or a clinical diagnosis of shift-work disorder before approving coverage.

Step therapy requirements are also common. Some Kansas plans require a trial-and-failure of a less expensive stimulant (such as generic methylphenidate) before authorizing modafinil. The American Academy of Sleep Medicine clinical practice guidelines recommend modafinil as a first-line pharmacotherapy for narcolepsy type 2, which can support appeals against step therapy requirements when appropriate.

Check your plan's formulary directly through your insurer's online portal or by calling the member services number on your insurance card. Formularies change annually, and a drug covered in 2025 may shift tiers in 2026.

Compounded Modafinil in Kansas: Legality and Access

Compounded modafinil is legal in Kansas when prepared by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications for individual patients when a prescriber determines that a commercially available form does not meet the patient's clinical needs.

Kansas Board of Pharmacy regulations align with federal 503A requirements. A compounding pharmacy in Kansas must hold an active Kansas pharmacy license, compound pursuant to a valid prescription, and use bulk drug substances that meet USP or NF standards. The pharmacy cannot compound copies of commercially available products unless the prescriber documents a clinical difference (such as a different dose strength, an allergy to an inactive ingredient, or a need for a different dosage form like a suspension for patients who cannot swallow tablets).

Pricing for compounded modafinil varies widely. Some 503A pharmacies offer compounded modafinil at lower price points than commercially manufactured generics, though quality assurance differs between compounded and FDA-approved products. The FDA's guidance on compounding emphasizes that compounded drugs are not FDA-approved and do not undergo the same premarket review for safety, efficacy, and manufacturing consistency.

Before choosing a compounded product, confirm that the pharmacy holds current accreditation from the Pharmacy Compounding Accreditation Board (PCAB) or a similar body, and ask whether they perform potency and sterility testing on their modafinil preparations.

Telehealth Prescribing of Modafinil in Kansas

Kansas permits telehealth prescribing of modafinil with a valid prescriber-patient relationship established via audiovisual communication. The Kansas Telemedicine Act, updated through 2024 legislative sessions, allows physicians and advanced practice registered nurses to prescribe Schedule IV controlled substances like modafinil through telehealth platforms.

Practical steps for a Kansas resident seeking modafinil via telehealth: schedule a consultation through a platform that operates in Kansas (several national telehealth companies and Kansas-based practices offer sleep medicine consultations), provide medical records including any prior sleep studies, and discuss symptoms and treatment history with the prescriber during the video visit. The prescriber can then transmit the prescription electronically to your preferred Kansas pharmacy.

One consideration: the DEA's telemedicine prescribing rules for controlled substances have undergone changes in recent years. As of 2026, the DEA permits initial prescriptions of Schedule III through V substances via telemedicine without a prior in-person visit, provided the telehealth encounter meets state requirements. Modafinil, as a Schedule IV substance, falls within this framework.

Telehealth visits for modafinil typically cost between $75 and $200 for the consultation, depending on the platform. Some platforms bundle the consultation fee with follow-up visits and prescription management.

How to Find the Lowest Modafinil Price in Kansas

Several strategies can reduce your out-of-pocket cost for modafinil in Kansas below the $80 average.

Manufacturer and pharmacy discount programs. Teva Pharmaceuticals (which acquired Cephalon) has periodically offered savings cards for branded Provigil, though availability fluctuates. Generic modafinil discount cards from GoodRx, RxSaver, and similar platforms frequently show prices between $25 and $60 for 30 tablets of modafinil 200 mg at Kansas pharmacies. These prices change weekly, so check multiple platforms before filling.

Pharmacy shopping. Walmart and Costco pharmacies in Kansas often price generic modafinil $15 to $30 below the state average. You do not need a Costco membership to use the Costco pharmacy in Kansas. Independent pharmacies may price-match or beat chain pharmacy pricing if you ask.

90-day fills. Filling a 90-day supply instead of monthly can reduce the per-unit cost by 10% to 20% at many Kansas pharmacies. If your insurance covers modafinil, a mail-order pharmacy through your plan may offer the lowest copay for a 90-day supply.

Patient assistance programs. NeedyMeds and the Partnership for Prescription Assistance maintain databases of assistance programs that may cover modafinil for uninsured or underinsured Kansas residents. Eligibility usually requires household income below 200% to 400% of the federal poverty level.

The single most effective cost-reduction step: always ask for the cash price of generic modafinil before running it through insurance. For many Kansas patients, especially those with high-deductible plans, the discount card price beats the insurance price.

Clinical Considerations for Modafinil Use

Modafinil 200 mg taken once daily in the morning is the standard starting dose for narcolepsy and shift-work disorder. The FDA label recommends 200 mg once daily, though doses up to 400 mg per day have been studied. The US Modafinil in Narcolepsy Study Group found that 200 mg and 400 mg produced similar efficacy on the Multiple Sleep Latency Test, suggesting that the 400 mg dose does not offer consistent additional benefit for most patients (Ann Neurol 1998).

Common side effects include headache (reported in 34% of patients in clinical trials vs. 23% with placebo), nausea (11% vs. 3%), and nervousness (7% vs. 3%). Serious but rare adverse effects include Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms (DRESS), both of which the FDA has flagged in safety communications.

Modafinil induces CYP3A4 and inhibits CYP2C19, creating clinically relevant drug interactions. It reduces the efficacy of hormonal contraceptives (oral, patch, ring) and may alter levels of warfarin, cyclosporine, and certain anticonvulsants. The National Library of Medicine's DailyMed database provides the complete interaction profile. Women using hormonal contraception should use a backup method during modafinil therapy and for one month after discontinuation.

Prescribers in Kansas should also be aware that modafinil is increasingly prescribed off-label for conditions such as ADHD, fatigue associated with multiple sclerosis, and cognitive enhancement. A Cochrane systematic review of modafinil for cognitive enhancement in non-sleep-deprived individuals found limited evidence of benefit and noted methodological limitations across available studies (Cochrane Database Syst Rev). Off-label use is not covered by Kansas Medicaid and may face insurance denials on commercial plans as well.

Kansas-Specific Pharmacy and Regulatory Notes

The Kansas Board of Pharmacy regulates all dispensing of modafinil within the state. As a Schedule IV controlled substance under both federal and Kansas law (K.S.A. 65-4113), modafinil prescriptions are valid for six months from the date written and may include up to five refills within that period.

Kansas does participate in the PMP InterConnect program, which allows prescribers and pharmacists to check the Kansas Prescription Drug Monitoring Program (K-TRACS) database before dispensing controlled substances. While K-TRACS checks are not mandatory for every Schedule IV prescription fill in Kansas, many pharmacies query the system as standard practice.

Out-of-state prescriptions for modafinil are accepted at Kansas pharmacies provided the prescription was issued by a prescriber licensed in their respective state and the prescription meets Kansas Board of Pharmacy requirements for controlled substance prescriptions. This is relevant for Kansas residents who obtain modafinil prescriptions through out-of-state telehealth providers.

Kansas residents near the Missouri or Nebraska borders sometimes fill prescriptions across state lines to take advantage of lower pricing. This is legal, though your insurance network may not cover out-of-state pharmacies.